Stockholm Stock Exchange | Small Cap
Medivir
+44.93%
Latest
-
3 months
Handelsbanken

Price Targets

Latest price targets per analyst.

AnalystPrice TargetDateUpside
Handelsbanken11 SEKJan -21
+44.93%

About The Company

Medivir is a Swedish biotechnology company. The company was founded in 1988 as a spin-off of Astra Zeneca's antiviral research unit. In 1996, Medivir was listed on Nasdaq OMX, the Stockholm Stock Exchange's midcap list of medium-sized companies. Wikipedia